Kırıkkale University   Report issue

Academic/Hospital Phase 3
Founded: Kırıkkale Turkey (1992)

Organization Overview

First Clinical Trial
2013
NCT02397122
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Associate professor at Kırıkkale University | Chest Diseases Specialist at Kırıkkale High Specialization Hospital | Esra DOĞAN YILMAZ, RN, MSc | Graduate student at Kırıkkale University | Kirikkale Univercity | Kırıkkale University | Kırıkkale University Faculty of Dentistry | Kırıkkale University Faculty of Medicine | Merve Erkmen Almaz

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 8